341 related articles for article (PubMed ID: 9032596)
1. [Fundamental and clinical studies on the efficacy of bifonazole in patients with tinea pedis at 10 years after approval. Part 2. Clinical evaluation].
Watanabe S; Takahashi H; Nakamura Y; Nakamura E; Nishiyama Y; Teduka M; Yamaguchi H; Uchida K; Tomizawa T; Shimozuma M; Osada A; Kawano S; Nakauchi Y; Wakukawa M; Goto A; Ueda Y; Matsukawa A; Minami H; Arikawa J; Soma Y; Chi HI; Tamaki K
Jpn J Antibiot; 1996 Dec; 49(12):1095-108. PubMed ID: 9032596
[TBL] [Abstract][Full Text] [Related]
2. [Usefulness of bifonazole for treatment of tinea pedis in the 20th year after approval].
Mitsui H; Kanda N; Ohnishi T; Nakai K; Suzuki T; Watanabe S
Jpn J Antibiot; 2009 Apr; 62(2):79-89. PubMed ID: 19673350
[TBL] [Abstract][Full Text] [Related]
3. A comparative clinical study between 2 weeks of luliconazole 1% cream treatment and 4 weeks of bifonazole 1% cream treatment for tinea pedis.
Watanabe S; Takahashi H; Nishikawa T; Takiuchi I; Higashi N; Nishimoto K; Kagawa S; Yamaguchi H; Ogawa H
Mycoses; 2006 May; 49(3):236-41. PubMed ID: 16681817
[TBL] [Abstract][Full Text] [Related]
4. [Preclinical and clinical studies on the efficacy of bifonazole in patients with tinea pedis at 10 years after approval. Part 1. Susceptibility to bifonazole of clinical isolates of dermatophytes].
Yamaguchi H; Uchida K; Watanabe S; Takahashi H; Nakamura Y; Nakamura E; Nishiyama Y; Teduka M; Tomizawa T; Shimozuma M; Osada A; Kawano S; Nakauchi Y; Wakukawa M; Goto A; Ueda Y; Matsukawa A; Kubo M; Minami H; Arikawa J; Soma Y; Chi HI; Tamaki K
Jpn J Antibiot; 1996 Dec; 49(12):1085-94. PubMed ID: 9032595
[TBL] [Abstract][Full Text] [Related]
5. Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology.
Croxtall JD; Plosker GL
Drugs; 2009; 69(3):339-59. PubMed ID: 19275277
[TBL] [Abstract][Full Text] [Related]
6. Antifungal activity of the new agent latoconazole in two tinea models.
Ohmi T; Konaka S; Uchida M; Yamaguchi H
Arzneimittelforschung; 1991 Aug; 41(8):847-51. PubMed ID: 1781809
[TBL] [Abstract][Full Text] [Related]
7. Dose-finding comparative study of 2 weeks of luliconazole cream treatment for tinea pedis--comparison between three groups (1%, 0.5%, 0.1%) by a multi-center randomised double-blind study.
Watanabe S; Takahashi H; Nishikawa T; Takiuchi I; Higashi N; Nishimoto K; Kagawa S; Yamaguchi H; Ogawa H
Mycoses; 2007 Jan; 50(1):35-40. PubMed ID: 17302746
[TBL] [Abstract][Full Text] [Related]
8. Tinea pedis acquired in mosques?
Veraldi S; Esposito L; Gorani A
Mycoses; 2018 Nov; 61(11):794-795. PubMed ID: 29600810
[TBL] [Abstract][Full Text] [Related]
9. Ciclopirox olamine lotion 1%: bioequivalence to ciclopirox olamine cream 1% and clinical efficacy in tinea pedis.
Aly R; Maibach HI; Bagatell FK; Dittmar W; Hänel H; Falanga V; Leyden JJ; Roth HL; Stoughton RB; Willis I
Clin Ther; 1989; 11(3):290-303. PubMed ID: 2663159
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of once-daily luliconazole 1% cream in patients ≥12 years of age with interdigital tinea pedis: a phase 3, randomized, double-blind,vehicle-controlled study.
Jarratt M; Jones T; Adelglass J; Bucko A; Pollak R; Roman-Miranda A; Olin JT; Swinyer L
J Drugs Dermatol; 2014 Jul; 13(7):838-46. PubMed ID: 25007368
[TBL] [Abstract][Full Text] [Related]
11. Naftifine Hydrochloride Gel 2%: An Effective Topical Treatment for Moccasin-Type Tinea Pedis.
Stein Gold LF; Vlahovic T; Verma A; Olayinka B; Fleischer AB
J Drugs Dermatol; 2015 Oct; 14(10):1138-44. PubMed ID: 26461826
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of naftifine HCl Gel 2% in the treatment of interdigital and moccasin type tinea pedis: pooled results from two multicenter, randomized, double-blind, vehicle-controlled trials.
Stein Gold LF; Parish LC; Vlahovic T; Plaum S; Kircik L; Fleischer AB; Verma A; Olayinka B; Hardas B
J Drugs Dermatol; 2013 Aug; 12(8):911-8. PubMed ID: 23986165
[TBL] [Abstract][Full Text] [Related]
13. A case of bullous tinea pedis with dermatophytid reaction caused by Trichophyton violaceum.
Romano C; Rubegni P; Ghilardi A; Fimiani M
Mycoses; 2006 May; 49(3):249-50. PubMed ID: 16681820
[TBL] [Abstract][Full Text] [Related]
14. Bifonazole (Mycospor cream) in the treatment of moccasin-type tinea pedis. Comparison between combination therapy of bifonazole cream + 10% urea ointment (Urepearl) and occlusive dressing therapy with the same agents.
Tanuma H; Doi M; Sato N; Nishiyama S; Abe M; Kume H; Katsuoka K
Mycoses; 2000; 43(3-4):129-37. PubMed ID: 10907343
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of flutrimazole 1% powder in the treatment of tinea pedis.
Pereda J; Noguera X; Boncompte E; Algueró M; Izquierdo I
Mycoses; 2003 Apr; 46(3-4):126-31. PubMed ID: 12870201
[TBL] [Abstract][Full Text] [Related]
16. Once-daily luliconazole cream 1% for the treatment of interdigital tinea pedis.
Gold MH; Olin JT
Expert Rev Anti Infect Ther; 2015; 13(12):1433-40. PubMed ID: 26559086
[TBL] [Abstract][Full Text] [Related]
17. Achievement of complete mycological cure by topical antifungal agent NND-502 in guinea pig model of tinea pedis.
Uchida K; Tanaka T; Yamaguchi H
Microbiol Immunol; 2003; 47(2):143-6. PubMed ID: 12680717
[TBL] [Abstract][Full Text] [Related]
18. Comparison of an antifungal agent used alone with an antifungal used with a topical steroid in inflammatory tinea pedis.
Elewski BE; Jones T; Zaias N
Cutis; 1996 Oct; 58(4):305-7. PubMed ID: 8894432
[TBL] [Abstract][Full Text] [Related]
19. Oxiconazole nitrate: pharmacology, efficacy, and safety of a new imidazole antifungal agent.
Jegasothy BV; Pakes GE
Clin Ther; 1991; 13(1):126-41. PubMed ID: 2029718
[TBL] [Abstract][Full Text] [Related]
20. Treatment of tinea pedis interdigitalis with bifonazole, 1% gel.
Galimberti RL; Belli L; Negroni R; Castro JM; Rohwedder R; Tuculet MA
Dermatologica; 1984; 169 Suppl 1():107-9. PubMed ID: 6396112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
